Havinga T K, ten Berge B S, May J F, Schuurman F H, van der Veur E, Wesseling H
Groningen Hypertension Service, The Netherlands.
Neth J Med. 1991 Feb;38(1-2):13-7.
After screening a local population in the northern part of The Netherlands for hypertension, 125 patients (116 of whom had not previously used antihypertensive drugs) with a five times elevated diastolic pressure (DP) of between 95 and 130 mmHg were randomized and treated daily either with atenolol 50 mg o.d. (n = 62) or with captopril 25 mg b.i.d. (n = 63) for 2 months under double-blind conditions. During this period the DP fell by 9 mm under atenolol (from 107 +/- 8 to 98 +/- 8) and by 8 mm under captopril (from 107 +/- 7 to 99 +/- 9). The number of responders with a DP = less than 90 mmHg was 21% and 20%, respectively. After 2 months the double-blind period was ended and the patients were submitted to a medication protocol for another 4 months in which an increased dose and additional nifedipine were given to non-responders. The response rate rose to 76% (atenolol/nifedipine combination) and to 60% (captopril/nifedipine combination) - NS. It is concluded that low doses of atenolol and captopril are equally effective in lowering blood pressure in uncomplicated mild to moderate hypertension.
在荷兰北部对当地人群进行高血压筛查后,125名舒张压(DP)升高5倍、在95至130 mmHg之间的患者(其中116名此前未使用过抗高血压药物)被随机分组,并在双盲条件下每日接受阿替洛尔50 mg(n = 62)或卡托普利25 mg,每日两次(n = 63)治疗2个月。在此期间,阿替洛尔治疗组的舒张压下降了9 mmHg(从107±8降至98±8),卡托普利治疗组下降了8 mmHg(从107±7降至99±9)。舒张压≤90 mmHg的有效应答者比例分别为21%和20%。2个月后双盲期结束,患者进入另一个4个月的用药方案,对无反应者增加剂量并加用硝苯地平。有效应答率分别升至76%(阿替洛尔/硝苯地平联合用药)和60%(卡托普利/硝苯地平联合用药),差异无统计学意义。结论是低剂量的阿替洛尔和卡托普利在降低单纯性轻至中度高血压患者的血压方面同样有效。